Rising Prostate Cancer Rates in South Korea: A Guide to Symptoms, Screening and Treatment

Prostate cancer is now the most commonly diagnosed cancer in South Korean men, a significant increase over the past decade. While survival rates are high with early detection, delayed diagnosis can lead to more aggressive treatment and reduced prognosis. This article provides a comprehensive overview of prostate cancer in South Korea, covering symptoms, screening recommendations, treatment options, and associated costs.

Prostate Cancer Incidence in South Korea

According to the ‘2023 National Cancer Registration Statistics’ released by the Ministry of Health and Welfare, National Cancer Center, and National Data Agency, prostate cancer accounted for 15.1% of new cancer cases in men, making it the most prevalent male cancer in the country. The number of new patients has approximately doubled in the last ten years, rising from around 9,000 in 2011.

This increase is likely due to a combination of factors, including the country’s aging population – with over 20% of the population projected to be 65 or older by 2025 – and lifestyle changes such as meat-centered diets, obesity, and lack of physical activity. Similar trends are observed globally, with prostate cancer being the most common cancer among American men, as reported by the American Cancer Society (ACS) in 2024.

Symptoms of Prostate Cancer

Early-stage prostate cancer often presents with no noticeable symptoms. As the cancer progresses, men may experience:

• Nocturia: Waking up repeatedly to urinate, more than twice during the night.
• Delayed Urination: Difficulty initiating urination.
• Weak Urine Stream: A thinner, less powerful urine stream (senyo).
• Residual Urine: A sensation of incomplete bladder emptying.
• Urgency: A sudden, compelling necessitate to urinate.

It’s crucial to consult a urologist if these symptoms persist, rather than attributing them solely to aging.

Prognosis and Survival Rates

The 5-year relative survival rate for prostate cancer is 96.0%. However, this rate significantly decreases to around 30% if the cancer has metastasized to other organs, such as the bones. Early detection is therefore critical for improving treatment outcomes.

If prostate cancer is discovered in the metastatic stage, curative surgery may not be possible, and some newer drug treatments can be very expensive, potentially costing several million won per month if not covered by health insurance.

Prostate Cancer Screening in South Korea

Currently, prostate cancer is not included in South Korea’s national cancer screening program. While a prostate-specific antigen (PSA) test can aid in early detection, concerns regarding overdiagnosis and cost-effectiveness have led health authorities to maintain a cautious approach to widespread screening.

The Korean Urological Association recommends that men over 50 discuss the potential benefits and risks of PSA testing with a specialist. The PSA test is a simple blood test available at most clinics, with an out-of-pocket cost of around 10,000 won, depending on the medical institution.

Treatment Costs

Treatment costs for prostate cancer can vary significantly depending on the chosen method and the hospital. Robotic surgery, while increasingly common, can exceed 10 million won in some cases if not fully reimbursed by insurance. Given the wide range of treatment options and associated costs, experts emphasize the importance of individualized counseling to determine the most appropriate course of action.

Key Takeaways

• Prostate cancer is the most common cancer in South Korean men and is increasing in incidence.
• Early detection is crucial for improving survival rates.
• Men over 50 should discuss PSA testing with their doctor.
• Treatment costs can vary significantly, so understanding your options is essential.